<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-61375</identifier>
<setSpec>0210-5705</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy(PPI,amoxicillin and clarithromycin) or sequential therapy(PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?</dc:title>
<dc:creator>Sánchez-Delgado, Jordi</dc:creator>
<dc:language>es</dc:language>
<dc:source>Gastroenterol Hepatol;32(1): 68-69, ene. 2009.</dc:source>
<dc:identifier>ibc-61375</dc:identifier>
<dc:title xml:lang="es">¿Cuál es actualmente el tratamiento erradicador de Helicobacter pylori de primera elección: la terapia triple (inhibidores de la bomba de protones [IBP], amoxicilina y claritromicina) o la terapia secuencial (IBP y amoxicilina durante 5 días, seguido de IBP, claritromicina y metronidazol durante otros 5 días)?</dc:title>
<dc:subject>^d29156^s22021</dc:subject>
<dc:subject>^d29157^s22057</dc:subject>
<dc:subject>^d8985^s22073</dc:subject>
<dc:subject>^d52844^s22073</dc:subject>
<dc:subject>^d673^s22073</dc:subject>
<dc:subject>^d29156^s22052</dc:subject>
<dc:subject>^d30785^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29157^s22027</dc:subject>
<dc:subject>^d4419</dc:subject>
<dc:type>article</dc:type>
<dc:date>200901</dc:date>
</metadata>
</record>
</ibecs-document>
